Target
Growth hormone secretagogue receptor type 1
Ligand
BDBM21943
Substrate
BDBM10852
Meas. Tech.
Fluorescence Imaging Plate Reader (FLIPR) Assay
pH
7.2±n/a
Temperature
295.15±n/a K
EC50
5.5±n/a nM
Citation
 Li, JChen, SYLi, JJWang, HHernandez, ASTao, SMusial, CMQu, FSwartz, SChao, STFlynn, NMurphy, BJSlusarchyk, DASeethala, RYan, MSleph, PGrover, GSmith, MABeehler, BGiupponi, LDickinson, KEZhang, HHumphreys, WGPatel, BPSchwinden, MStouch, TCheng, PTBiller, SAEwing, WRGordon, DRobl, JATino, JA Discovery of a tetrazole-based growth hormone secretagogue: 4-(hydroxybutyl)carbamic acid 2-{5-[1-(2-amino-2-methylpropionylamino)-2- benzyloxyethyl]tetrazol-1-yl}ethyl ester (BMS-317180). J Med Chem 50:5890-3 (2007) [PubMed]  Article 
Target
Name:
Growth hormone secretagogue receptor type 1
Synonyms:
GH-releasing peptide receptor | GHRP | GHS-R | GHSR | GHSR_HUMAN | Ghrelin Receptor (Growth Hormone Secretagogue Receptor Type 1) | Ghrelin receptor | Ghrelin receptor 1a (GHS-R1a)
Type:
Receptor
Mol. Mass.:
41334.57
Organism:
Homo sapiens (Human)
Description:
Receptor binding studies use plasma membranes from LLC PK-1 cells transiently transfected with hGHSR1a.
Residue:
366
Sequence:
MWNATPSEEPGFNLTLADLDWDASPGNDSLGDELLQLFPAPLLAGVTATCVALFVVGIAGNLLTMLVVSRFRELRTTTNLYLSSMAFSDLLIFLCMPLDLVRLWQYRPWNFGDLLCKLFQFVSESCTYATVLTITALSVERYFAICFPLRAKVVVTKGRVKLVIFVIWAVAFCSAGPIFVLVGVEHENGTDPWDTNECRPTEFAVRSGLLTVMVWVSSIFFFLPVFCLTVLYSLIGRKLWRRRRGDAVVGASLRDQNHKQTVKMLAVVVFAFILCWLPFHVGRYLFSKSFEPGSLEIAQISQYCNLVSFVLFYLSAAINPILYNIMSKKYRVAVFRLLGFEPFSQRKLSTLKDESSRAWTESSINT
  
Inhibitor
Name:
BDBM21943
Synonyms:
2-{5-[(1S)-1-(2-amino-2-methylpropanamido)-2-(benzyloxy)ethyl]-1H-1,2,3,4-tetrazol-1-yl}ethyl N-(3-hydroxypropyl)carbamate | Tetrazole-based compound, 9
Type:
Small organic molecule
Emp. Form.:
C20H31N7O5
Mol. Mass.:
449.504
SMILES:
CC(C)(N)C(=O)N[C@H](COCc1ccccc1)c1nnnn1CCOC(=O)NCCCO |r|
Structure:
Search PDB for entries with ligand similarity:
Substrate